SCHEMBL8074960

SCHEMBL8074960

CC(C)(C)OC(=O)NCc1ccc(C(=O)Nc2nc(Cl)ccc2[N+](=O)[O-])cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAMPT P43490 2/20 0.52
HDAC1 Q13547 3/20 0.46
MAPT P10636 7/20 0.45
HTT P42858 3/20 0.44
L3MBTL1 Q9Y468 2/20 0.42
HDAC6 Q9UBN7 2/20 0.41
HDAC10 Q969S8 1/20 0.41
NPSR1 Q6W5P4 4/20 0.40
CYP1A2 P05177 3/20 0.40
CYP2C19 P33261 3/20 0.40
CYP3A4 P08684 2/20 0.40
GPR55 Q9Y2T6 2/20 0.40
LMNA P02545 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
GAA P10253 1/20 0.40
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
TDP1 Q9NUW8 2/20 0.39
RECQL P46063 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8078115 0.90 MAPT (0.48) HDAC1MAPTHTTL3MBTL1NPSR1
SCHEMBL2177544 0.86 BRD4 (0.48) NAMPTMAPTHTTL3MBTL1NPSR1
SCHEMBL3643236 0.85 MAPT (0.53) MAPTHTTL3MBTL1CYP1A2CYP2C19
SCHEMBL3643232 0.85 MAPT (0.53) MAPTHTTL3MBTL1CYP1A2CYP2C19
SCHEMBL8083578 0.79 HDAC1 (0.60) NAMPTHDAC1MAPTHTTLMNA
SCHEMBL3813745 0.78 MAPT (0.57) MAPTHTTNPSR1CYP1A2CYP2C19
SCHEMBL3646356 0.78 NAMPT (0.48) NAMPTHDAC1HTTL3MBTL1HDAC6
SCHEMBL27782675 0.77 MERTK (0.56) MAPTHTTL3MBTL1CYP3A4LMNA
SCHEMBL3768459 0.77 MAPT (0.51) HDAC1MAPTHTTHDAC6LMNA
SCHEMBL3768460 0.77 MAPT (0.51) HDAC1MAPTHTTHDAC6LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2170339-B1 PYRIDYL AND PYRIMIDINYL DERIVATIVES AS HISTONE DEACETYLASE INHIBITORS MERCK SHARP & DOHME (US) 2014-10-15 EP disclosed
US-8461189-B2 Pyridyl derivatives as histone deacetylase inhibitors MERCK SHARP & DOHME CORP. (US) 2013-06-11 US disclosed
US-8461189-B2 Pyridyl derivatives as histone deacetylase inhibitors MERCK SHARP & DOHME CORP. (US) 2013-06-11 US disclosed
US-20100324092-A1 PYRIDYL AND PYRIMIDINYL DERIVATIVES AS HISTONE DEACETYLASE INHIBITORS MERCK SHARP & DOHME CORP. 2010-12-23 US disclosed
WO-2009005638-A2 PYRIDYL AND PYRIMIDINYL DERIVATIVES AS HISTONE DEACETYLASE INHIBITORS MERCK & CO., INC. (US) 2009-01-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100324092-A1 PYRIDYL AND PYRIMIDINYL DERIVATIVES AS HISTONE DEACETYLASE INHIBITORS BRDT, HDAC5, HDAC1 NAMPT 63/4885HDAC1 3/4885MAPT 1335/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.